Heather R. Macdonald
Research Subjects
Research Interests
Heather R. Macdonald has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Colleen Coleman
Surgery, Hoag Family Cancer Institute, Newport Beach, California
2 shared publications- David M. Goodman
Boston College
2 shared publications Howard Silberman
Norris Cancer Hospital, Los Angeles, CA
2 shared publicationsSara Carabbio-Thopsey
2 shared publications- Agustin A. Garcia
Keck School of Medicine of the University of Southern California
1 shared publication - Audrey Mauguen
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
1 shared publication
Latest Publications
- Open Access
- 1 July 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (7) , e2423435
ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer
Importance: There are insufficient data comparing 16α-18F-fluoro-17β-estradiol (FES) positron emission tomography (PET) computed tomography (CT) with standard-of-care imaging (SOC) for staging locally advanced breast cancer (LABC) or evaluating suspected recurrence.Objective: To determine the detection rate of FES PET/CT and SOC for distant metastases in patients with estrogen receptor (ER)-positive LABC and recurrences in patients with ER-positive BC and suspected recurrence.Design, Setting, and Participants: This diagnostic study was conducted as a single-center phase 2 trial, from January 2021 to September 2023. The study design provided 80% power to find a 20% detection rate difference. Participants included patients with ER-positive LABC (cohort 1) or suspected recurrence (cohort 2). Data were analyzed from September 2023 to February 2024.Exposure: Participants underwent both SOC imaging and experimental FES PET/CT. When there were suspicious lesions on imaging, 1 was biopsied for histopathological reference standard to confirm presence (true positive) or absence (false positive) of malignant neoplasm.Main Outcomes and Measures: The outcome of interest was the detection rate of FES PET CT vs SOC for distant metastases and recurrences.Results: A total of 124 patients were accrued, with 62 in cohort 1 (median [IQR] age, 52 [32-84] years) and 62 in cohort 2 (median [IQR] age, 66 [30-93] years). In cohort 1, of 14 true-positive findings, SOC imaging detected 12 and FES detected 11 (P > .99). In cohort 2, of 23 true-positive findings, SOC detected 16 and FES detected 18 (P = .77). In 30 patients with lobular histology, of 11 true-positive findings, SOC detected 5 and FES detected 9 (P = .29). There were 6 false-positive findings on SOC and 1 false-positive finding on FES PET/CT (P = .13).Conclusions and Relevance: In this diagnostic study with pathological findings as the reference standard, no difference was found between FES PET/CT and current SOC imaging for detecting distant metastases in patients with ER-positive LABC or recurrences in patients with ER-positive tumors and suspected recurrence. FES PET/CT could be considered for both clinical indications, which are not part of current Appropriate Use Criteria for FES PET. The findings regarding FES PET/CT in patients with lobular tumors, and for lower false positives than current SOC imaging, warrant further investigation.
- 1 July 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (7) , e2423435
Open AccessER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer
Importance: There are insufficient data comparing 16α-18F-fluoro-17β-estradiol (FES) positron emission tomography (PET) computed tomography (CT) with standard-of-care imaging (SOC) for staging locally advanced breast cancer (LABC) or evaluating suspected recurrence.Objective: To determine the detection rate of FES PET/CT and SOC for distant metastases in patients with estrogen receptor (ER)-positive LABC and recurrences in patients with ER-positive BC and suspected recurrence.Design, Setting, and Participants: This diagnostic study was conducted as a single-center phase 2 trial, from January 2021 to September 2023. The study design provided 80% power to find a 20% detection rate difference. Participants included patients with ER-positive LABC (cohort 1) or suspected recurrence (cohort 2). Data were analyzed from September 2023 to February 2024.Exposure: Participants underwent both SOC imaging and experimental FES PET/CT. When there were suspicious lesions on imaging, 1 was biopsied for histopathological reference standard to confirm presence (true positive) or absence (false positive) of malignant neoplasm.Main Outcomes and Measures: The outcome of interest was the detection rate of FES PET CT vs SOC for distant metastases and recurrences.Results: A total of 124 patients were accrued, with 62 in cohort 1 (median [IQR] age, 52 [32-84] years) and 62 in cohort 2 (median [IQR] age, 66 [30-93] years). In cohort 1, of 14 true-positive findings, SOC imaging detected 12 and FES detected 11 (P > .99). In cohort 2, of 23 true-positive findings, SOC detected 16 and FES detected 18 (P = .77). In 30 patients with lobular histology, of 11 true-positive findings, SOC detected 5 and FES detected 9 (P = .29). There were 6 false-positive findings on SOC and 1 false-positive finding on FES PET/CT (P = .13).Conclusions and Relevance: In this diagnostic study with pathological findings as the reference standard, no difference was found between FES PET/CT and current SOC imaging for detecting distant metastases in patients with ER-positive LABC or recurrences in patients with ER-positive tumors and suspected recurrence. FES PET/CT could be considered for both clinical indications, which are not part of current Appropriate Use Criteria for FES PET. The findings regarding FES PET/CT in patients with lobular tumors, and for lower false positives than current SOC imaging, warrant further investigation.
- 2 December 2023
- Published by Springer Nature
- p. 485-493
Management of Benign Breast Disease
- 2 December 2023
- Published by Springer Nature
- p. 417-426
Breast Cancer Screening
- 3 June 2023
- Published by Springer Nature
- p. 1-10
Breast Cancer Screening
- 25 April 2023
- Published by Springer Nature
- p. 1-9
Management of Benign Breast Disease
- 17 May 2022
- Published by Taylor & Francis
- p. 1-13
Introduction
Goodman, Macdonald, and Carabbio-Thopsey frame the volume and its chapters by establishing the context of the birthplace of psychology as a discipline and the unique pressures and sociopolitical requirements placed upon its formation and function. This sets the stage for the varied critiques and explorations by the scholars and clinicians in the chapters that follow.
- 17 May 2022
- Published by Taylor & Francis
- p. 1-13
Introduction
Goodman, Macdonald, and Carabbio-Thopsey frame the volume and its chapters by establishing the context of the birthplace of psychology as a discipline and the unique pressures and sociopolitical requirements placed upon its formation and function. This sets the stage for the varied critiques and explorations by the scholars and clinicians in the chapters that follow.
- 17 May 2022
- Published by Taylor & Francis
- p. 44-83
Subjectivity and the Critical Imagination in Neoliberal Capitalism
Thomas Teo and Dennis Wendt enter a dialogue about psychology’s entanglement with society, culture, and the history of psychology. Their discussion highlights important aspects of Teo’s recent scholarship that aims at defining a critical psychology agenda that works to disrupt the epistemological violence and ‘epistemological grandiosity’ that structures psychological discourse. In his scholarship, Teo also identifies psychology as a “hyperscience,” a discipline that uses strategies to hide the fact that it is not a natural science (Teo, in press). In order to do that, one inflates and complicates one’s methodological activities, conceals the temporality and contextuality of psychological phenomena and incessantly refers to one’s discipline as a science.
- 17 May 2022
- Published by Taylor & Francis
- p. 44-83
Subjectivity and the Critical Imagination in Neoliberal Capitalism
Thomas Teo and Dennis Wendt enter a dialogue about psychology’s entanglement with society, culture, and the history of psychology. Their discussion highlights important aspects of Teo’s recent scholarship that aims at defining a critical psychology agenda that works to disrupt the epistemological violence and ‘epistemological grandiosity’ that structures psychological discourse. In his scholarship, Teo also identifies psychology as a “hyperscience,” a discipline that uses strategies to hide the fact that it is not a natural science (Teo, in press). In order to do that, one inflates and complicates one’s methodological activities, conceals the temporality and contextuality of psychological phenomena and incessantly refers to one’s discipline as a science.
- 16 May 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1771-1780
Autologous mastectomy reconstruction: Communication among the breast surgery team to maximize aesthetic and oncologic outcome
Mastectomy breast reconstruction with autologous tissue is challenging. Oncologic and aesthetic goals face previous surgical scars, radiation, chemotherapy, or other comorbidities. We describe a simple approach for autologous mastectomy reconstruction so that breast and plastic and reconstructive surgeons can maximize aesthetic outcomes and minimize wound complications. A retrospective chart review was done on patients who underwent mastectomy and autologous reconstruction. The surgical flight plans were reviewed to delineate an approach, and pre‐ and postoperative photographs were examined to create a step‐by‐step process. The most encountered mastectomy and autologous flap reconstruction scenarios were categorized to create a step‐by‐step process. Successful autologous mastectomy reconstruction to optimize aesthetic outcome and minimize complications requires team communication. Creation of a surgical flight plan using information from the physical examination, MRI and adjunctive imaging, and preoperative photographs is imperative. Thoughtful incision choice and exposure approach are paramount.
- 16 May 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1771-1780
Autologous mastectomy reconstruction: Communication among the breast surgery team to maximize aesthetic and oncologic outcome
Mastectomy breast reconstruction with autologous tissue is challenging. Oncologic and aesthetic goals face previous surgical scars, radiation, chemotherapy, or other comorbidities. We describe a simple approach for autologous mastectomy reconstruction so that breast and plastic and reconstructive surgeons can maximize aesthetic outcomes and minimize wound complications. A retrospective chart review was done on patients who underwent mastectomy and autologous reconstruction. The surgical flight plans were reviewed to delineate an approach, and pre‐ and postoperative photographs were examined to create a step‐by‐step process. The most encountered mastectomy and autologous flap reconstruction scenarios were categorized to create a step‐by‐step process. Successful autologous mastectomy reconstruction to optimize aesthetic outcome and minimize complications requires team communication. Creation of a surgical flight plan using information from the physical examination, MRI and adjunctive imaging, and preoperative photographs is imperative. Thoughtful incision choice and exposure approach are paramount.
- 14 January 2020
- Published by Wiley in The Breast Journal
- Vol. 26 (1) , 81-85
Pregnancy associated breast cancer
Pregnancy associated breast cancer (PABC) defined as breast cancer occurring during pregnancy or within the first 1-2 years postpartum. Delay in diagnosis is common. Treatment is timed around gestational age. Surgery and chemotherapy are considered safe after the first trimester. Radiation, anti-her-2, and endocrine therapy are delayed until after delivery due to adverse fetal effects. Iatrogenic prematurity likely causes most long-term fetal sequelae. Multi-disciplinary care and social support are critical for patients and families with PABC.
- 14 January 2020
- Published by Wiley in The Breast Journal
- Vol. 26 (1) , 81-85
Pregnancy associated breast cancer
Pregnancy associated breast cancer (PABC) defined as breast cancer occurring during pregnancy or within the first 1-2 years postpartum. Delay in diagnosis is common. Treatment is timed around gestational age. Surgery and chemotherapy are considered safe after the first trimester. Radiation, anti-her-2, and endocrine therapy are delayed until after delivery due to adverse fetal effects. Iatrogenic prematurity likely causes most long-term fetal sequelae. Multi-disciplinary care and social support are critical for patients and families with PABC.
- 23 July 2019
- Published by Wiley in The Breast Journal
- Vol. 25 (6) , 1063-1065
Managing breast cancer risk in transgender men and women: Emerging safety data and a need for more research
- 23 July 2019
- Published by Wiley in The Breast Journal
- Vol. 25 (6) , 1063-1065
Managing breast cancer risk in transgender men and women: Emerging safety data and a need for more research